EP Wealth Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
EP Wealth Advisors's HALO Position: Q2 2026 in Review
EP Wealth Advisors increased its Halozyme (HALO) stake by 2.6% in Q2 2026, buying an estimated $14.9K and bringing the position to 8,761 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #885.
EP Wealth Advisors first reported a position in HALO in Q2 2019 and has held it in 23 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- EP Wealth Advisors held 8,761 shares of Halozyme worth $686K as of Q2 2026.
- EP Wealth Advisors bought 219 Halozyme shares in Q2 2026, an estimated $14.9K.
- Halozyme made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #885 holding.
- EP Wealth Advisors first reported a position in Halozyme in Q2 2019 and has held it in 23 quarters since.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.